Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,376,659
+$1,377,309 QoQ
Shares Held
386,810
+33.5% QoQ
Ownership
0.634%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Derivatives in JANX
reported options exposure · as of Jun 30, 2024CallValue
$448,223
CallShares
10,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. JANX ranks #165 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in JANX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,376,659 | 386,810 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,999,350 | 289,808 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,459,763 | 100,645 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,951,762 | 214,362 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,221,371 | 82,273 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,216,101 | 116,102 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $448,223 | 10,700 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $217,767 | 5,784 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $771,014 | 71,856 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,014,168 | 100,612 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,640,980 | 138,246 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $412,646 | 34,103 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $525,614 | 39,910 | Shares | Sole | 2023-02-14 | |
| 2021-06-30 | $1,877,662 | 75,257 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||